Revolution Medicines (RVMD) Property, Plant & Equipment (Net) (2019 - 2026)
Powered by 
Analysis
Revolution Medicines (RVMD) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.92 Bn | 133.07 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.02 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 64.96 Bn | 59.78 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 57.31 Bn | 52.17 Bn | 52.00 Mn | 2.06 Bn |
| 5 | Revolution Medicines | 44.60 Bn | 44.60 Bn | - | 34.61 Mn |
| 6 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 1.64 Bn |
| 7 | Alnylam Pharmaceuticals | 35.51 Bn | 32.21 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Royalty Pharma | 28.21 Bn | 27.37 Bn | - | - |
| 9 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 107.22 Mn |
| 10 | Incyte | 25.77 Bn | 21.23 Bn | 1.57 Bn | 709.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.61 Mn |
| Mar 31, 2026 | 31.48 Mn |
| Dec 31, 2025 | 33.19 Mn |
| Sep 30, 2025 | 32.93 Mn |
| Jun 30, 2025 | 33.05 Mn |
| Mar 31, 2025 | 27.15 Mn |
| Dec 31, 2024 | 24.29 Mn |
| Sep 30, 2024 | 24.81 Mn |
| Jun 30, 2024 | 25.28 Mn |
| Mar 31, 2024 | 23.70 Mn |
| Dec 31, 2023 | 22.87 Mn |
| Sep 30, 2023 | 20.29 Mn |
| Jun 30, 2023 | 19.72 Mn |
| Mar 31, 2023 | 18.54 Mn |
| Dec 31, 2022 | 18.66 Mn |
| Sep 30, 2022 | 18.27 Mn |
| Jun 30, 2022 | 15.91 Mn |
| Mar 31, 2022 | 13.06 Mn |
| Dec 31, 2021 | 11.54 Mn |
| Sep 30, 2021 | 10.11 Mn |